Back to Trades
Total Value
$88.7K
Net $88.7K bought
Filing Date
Jul 10, 2026
2 transactions
Purchases
$88.7K
2 transactions
Trade Summary
On Jul 8, 2026 through Jul 9, 2026, Baltera Robert Jr., Director, purchased $88.7K of PALISADE BIO, INC. (PALI) across 2 transactions. The filing covers Common Stock and reflects net buying of $88.7K. Reported prices ranged from $1.96 to $1.99. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- PALISADE BIO, INC.
- Ticker Symbol
- PALI
- CIK
- 0001357459
Insider Information
- Role
- Director
- Location
- DENVER, CO
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001493152-26-032884
- Form Type
- 4
- Net Trading Amount
- $88.7K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | 20,000 | $1.99 | Purchase | $39.8K |
| Jul 9, 2026 | Common Stock | 25,000 | $1.96 | Purchase | $48.9K |
Want live alerts when Baltera Robert Jr. trades again?
Download Insider Trades to track PALI, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- (F2)The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9298 to $1.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.